Protocol Ledger

NCT03667170 · Phase II · ACTIVE NOT RECRUITING

KN035 for dMMR/MSI-H Advanced Solid Tumors

Interventional Phase II clinical trial protocol NCT03667170 sponsored by 3D Medicines (Sichuan) Co in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-08-22 Enrollment: 188 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03667170
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)188 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03667170
Protocol FieldVerified Registry Value
NCT IdentifierNCT03667170
Consolidated Lead Sponsor3D Medicines (Sichuan) Co
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment188 participants (ACTUAL)
Registered Start Date2018-08-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI